GlassScriptPhysician profile
Jonathan Roger Henning
NPI 1518120823
$2,806.73
in general payments reported to CMS, 2019-2025
42 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $228 · 2021: $379 · 2022: $444 · 2023: $585 · 2024: $175 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.51 | 2019-2024 | |
| Caldera Medical, INC | $242.15 | 2023 | Desara |
| Janssen Biotech, INC. | $229.51 | 2019-2022 | |
| Astellas Pharma US INC | $211.19 | 2019-2025 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $174.91 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $155.56 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $140.84 | 2019-2025 | |
| Myovant Sciences INC. | $120.05 | 2021-2022 | |
| Boston Scientific Corporation | $114.22 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Edap Technomed INC | $87.00 | 2024 | |
| Accord Healthcare, INC. | $77.23 | 2022 | |
| Coloplast Corp | $72.70 | 2021-2025 | |
| Neotract INC. | $65.42 | 2019 | |
| Stryker Corporation | $65.02 | 2025 | Augment Injectable |
| Rochester Medical Corporation | $53.93 | 2020-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Henning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.